JP Morgan Maintains Underweight on Sotera Health, Lowers Price Target to $15
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Underweight and lowers the price target from $17 to $15.
JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Underweight and lowers the price target from $17 to $15.